References
- [1]. Segrè, Emilio; Seaborg, Glenn T., Nuclear Isomerism in Element 43, Physical Review1938 54 (9), 772–772.
- [2]. Eckelman, W. C., Unparalleled Contribution of Technetium-99m to Medicine Over 5 Decades, JACC: Cardiovascular Imaging2009 2 (3), 364–368, doi:10.1016/j.jcmg.2008.12.013.10.1016/j.jcmg.2008.12.013
- [3]. Arano, Y., Recent advances in Tc-99m radio pharmaceuticals, Annals of Nuclear Medicine2002 16(2):79-93.
- [4]. Banerjee, S; Pillai, M.R.A.; Ramamoorthy, N, Evolution of Tc-99m in diagnostic radiopharmaceuticals, Seminars in Nuclear Medicine2001 31(4):260-277.
- [5]. Saha, G; Fundamentals of Nuclear Pharmacy, Published by Springer New York2004 ISBN: 978-0-387-40360-1, DOI: 10.1007/b97503.
- [6]. Production technologies for molybdenum-99 and technetium-99m, IAEA-TECDOC-1065
- [7].https://humanhealth.iaea.org/HHW/Radiopharmacy/VirRad/Eluting_the_Generator/Generator_Module/Elution_of_the_99Mo99mTc_generator/Product_issues_with_eluted_99mTc/index.html
- [8]. Council of Europe (2005a) Sodium pertechnetate [99mTc] injection (fission). Monograph No. 124, European Pharmacopoeia, 5th edn., Maisonneuve, Sainte-Ruffine
- [9]. Council of Europe (2005b) Sodium pertechnetate [99mTc] injection (nonfission). Monograph No. 283. European Pharmacopoeia, 5th edn. Maisonneuve, Sainte-Ruffine
- [10]. Briner WH, Harris CC (1974) Radionuclide contamination of eluates from fission-product molyb denum-technetium generators. J Nucl Med 15:466±467
- [11]. IAEA. 2002, Specialized software utilities for gamma ray spectrometry. Final report of a co-ordinated research project 1996–2000, IAEA-TECDOC-1275, International Atomic Energy Agency, Vienna, Austria.